Akron Biotech to exclusively manufacture Human AB Serum for Octapharma
Akron Biotechnology (Akron Biotech) has signed an exclusive global agreement with Swiss-based Octapharma, to manufacture virally inactivated Human AB Serum for the cell therapy market.